Monarch Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.23M | Buy |
2,345
+941
| +67% | +$494K | 0.33% | 66 |
|
|
2025
Q1 | $890K | Buy |
1,404
+337
| +32% | +$214K | 0.25% | 69 |
|
|
2024
Q4 | $760K | Buy |
1,067
+549
| +106% | +$391K | 0.21% | 75 |
|
|
2024
Q3 | $545K | Sell |
518
-46
| -8% | -$48.4K | 0.15% | 88 |
|
|
2024
Q2 | $593K | Sell |
564
-20
| -3% | -$21K | 0.17% | 84 |
|
|
2024
Q1 | $562K | Hold |
584
| – | – | 0.16% | 84 |
|
|
2023
Q4 | $513K | Sell |
584
-29
| -5% | -$25.5K | 0.16% | 84 |
|
|
2023
Q3 | $504K | Sell |
613
-20
| -3% | -$16.5K | 0.16% | 84 |
|
|
2023
Q2 | $455K | Sell |
633
-15
| -2% | -$10.8K | 0.14% | 91 |
|
|
2023
Q1 | $532K | Hold |
648
| – | – | 0.16% | 80 |
|
|
2022
Q4 | $468K | Sell |
648
-3
| -0.5% | -$2.16K | 0.14% | 87 |
|
|
2022
Q3 | $448K | Sell |
651
-33
| -5% | -$22.7K | 0.15% | 85 |
|
|
2022
Q2 | $404K | Sell |
684
-5
| -0.7% | -$2.95K | 0.12% | 93 |
|
|
2022
Q1 | $481K | Buy |
689
+210
| +44% | +$147K | 0.13% | 90 |
|
|
2021
Q4 | $302K | Buy |
+479
| New | +$302K | 0.08% | 103 |
|